Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000...
FDA Drug Recall #D-1344-2014 — Class II — April 22, 2014
Recall Summary
| Recall Number | D-1344-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 22, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | SigmaPharm Laboratories LLC |
| Location | Bensalem, PA |
| Product Type | Drugs |
| Quantity | 43,007 Bottles |
Product Description
Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.
Reason for Recall
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Distribution Pattern
Nationwide and Puerto Rico
Lot / Code Information
Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015
Other Recalls from SigmaPharm Laboratories LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0898-2021 | Class II | Sodium Phenylbutyrate Powder, 250 Grams, Rx Onl... | Sep 21, 2021 |
| D-0766-2021 | Class II | Sodium Phenylbutyrate POWDER, 250 grams bottle,... | Aug 13, 2021 |
| D-0379-2021 | Class III | Asenapine Sublingual Tablets, 5 mg, Rx Only, 60... | Apr 19, 2021 |
| D-0380-2021 | Class III | Asenapine Sublingual Tablets, 10 mg, Rx only, 6... | Apr 19, 2021 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.